NexTel Medical Corp Oct 7, 2026 Copy link NexTel Medical Corp. Announces Next-Generation Wellness Product Line Incorporating FDA-Approved Pharmaceuticals Innovative Delivery Technologies Aimed at Enhancing Bioavailability and Expanding Patient Access Beyond Traditional Business
NexTel Medical Corp Sep 29, 2026 Copy link NexTel Medical Corp. Announces Strategic Joint Venture to Commercialize Breakthrough Patented Hair Regeneration Technology Capitalizing on a Global Hair Restoration Market Projected to Exceed $23 Billion, the Venture Integrates Advanced Business
NexTel Medical Corp Sep 25, 2026 Copy link NexTel Medical Corp. Showcases Pioneer Exosome Technologies and Diagnostic Innovations at Leading Healthcare Conference Company highlights ongoing clinical developments in traumatic brain injury (TBI) therapeutics and non-invasive cancer Business
NexTel Medical Corp Aug 6, 2026 Copy link NexTel Medical Corp. Clarifies and Expands Upon Remarks Made During Recent Online Discussion ORLANDO, FL / ACCESS Newswire / August 6, 2026 / NexTel Medical Corp. (f/k/a Exousia Pro, Inc.) (OTCID:MAJI) ("NexTel" Business
NexTel Medical Corp Aug 5, 2026 Copy link NexTel Medical Corp. Executes Letter of Intent to Acquire 100% of Xycota Biosciences, LLC Strategic Acquisition Positions NexTel at the Forefront of Precision Neuro-Restoration with Xycota's Breakthrough Business
NexTel Medical Corp Jul 28, 2026 Copy link NexTel Medical Corp. Advances Veterinary Oncology Strategy with Rollout of Early-Stage Cancer Screening for Companion Animals Company targets a growing $1.2B+ North American pet oncology market leveraging proprietary exosome-based diagnostic Animals Business